CAS 844873-47-8

Formel: C23H29N7O6

InChl: InChI=1S/C23H29N7O6/c1-35-23(34)29-9-7-12(8-10-29)3-2-4-14-27-19(24)15-20(28-14)30(11-25-15)22-17(32)16(31)18(36-22)21(33)26-13-5-6-13/h11-13,16-18,22,31-32H,3,5-10H2,1H3,(H,26,33)(H2,24,27,28)/t16-,17+,18-,22+/m0/s1

InChI Key: SQJXTUJMBYVDBB-RQXXJAGISA-N

SMILES: COC(=O)N1CCC(CC1)CC#CC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)C(=O)NC5CC5)O)O)N

Evodenoson

CAS: 844873-47-8

Evodenoson

Formel: C₂₃H₂₉N₇O₆

Reinheit: 99.5%

Molekulargewicht: 499.52

Ref: 54-BUP08055

Evodenoson

CAS: 844873-47-8

Formel: C₂₃H₂₉N₇O₆

Molekulargewicht: 499.5197

Ref: IN-DA024CD0

ATL-313-d4

Kontrolliertes Produkt

CAS: 844873-47-8

Applications Isotope labelled analogue of ATL-313, an adenosine A2A receptor agonists used as a potential treatment for spinal cord injury in preventing the apoptotic process that is an important step of secondary damage after spinal cord injury.
References Genovese, T., et al.: J. Biol. Reg. Homeo. Agent., 24, 73 (2010); Sharma. A.K., et al.: J. Thora. Cardiovas. Surg., 139. 474 (2010);

Formel: C₂₃D₄H₂₅N₇O₆

Farbe und Form: Neat

Molekulargewicht: 503.544

Ref: TR-A790502

Evodenoson

CAS: 844873-47-8

Evodenoson (ATL313), a potent A2aR agonist, treats eye diseases, tumors, and immune disorders; potential for glaucoma and blood cancer studies.

Formel: C₂₃H₂₉N₇O₆

Reinheit: 99.75% - 99.92%

Farbe und Form: Solid

Molekulargewicht: 499.5197

Ref: TM-T31731